ArticleThe Canadian veterinary journal = La revue veterinaire canadienne2025
A case of feline gastrointestinal eosinophilic sclerosing fibroplasia extending to the liver and jejunal lymph nodes.
Article in The Canadian veterinary journal = La revue veterinaire canadienne, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
An 8-year-old neutered male domestic shorthair cat with a history of persistent diarrhea and a previous diagnosis of feline gastrointestinal eosinophilic sclerosing fibroplasia in the jejunum was presented to our hospital. Abdominal ultrasound examination revealed a hepatic lesion with a diffuse altered echostructure. Histopathologic analysis confirmed the diagnosis of hepatic feline eosinophilic sclerosing fibroplasia (FESF), marked by multinodular lesions with abundant inflammatory cell infiltrates. Despite treatment with corticosteroids and supportive care, the cat was euthanized 15 d after diagnosis due to the deterioration of its health status. This report aims to highlight the necessity to include FESF within differential diagnoses when diagnosing liver masses in cats, particularly those with previous gastrointestinal involvement. It emphasizes the need for histopathologic confirmation and highlights the challenges in diagnosing this condition, especially regarding its multifocal nature and potential misdiagnosis as tumors. With only 2 documented cases of liver involvement available, the prognosis for hepatic FESF remains unclear, warranting further investigation to establish definitive therapeutic guidelines. Key clinical message: Feline eosinophilic sclerosing fibroplasia should be considered as a differential diagnosis for cats presented with liver masses. The diagnosis relies on careful history-taking and clinical examination, mainly in the presence of a previous gastrointestinal mass. Histopathologic evidence is essential for a definitive diagnosis.
Indexed as
Identifiers
41584246PMC12825731What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.